[6-K] ORIX CORP Current Report (Foreign Issuer)
ORIX Corporation reports a restricted-share issuance under an employee plan with a disposal price of ¥3,882 per share and a total contribution of ¥552,796,800. The filing states the paid-in amount from the contributions will not be incorporated into capital. The document lists two participant counts as "234 Persons" and "84 Persons" and describes the consideration as in-kind contributions of the Monetary Grant held by Eligible Employees, which will be provided by the company or its subsidiaries for the Restricted Shares. The filing provides basic transaction values and participant counts but does not include further detail on allocation, vesting, or impact on outstanding share count.
- Clear monetary disclosure: Total contribution amount of ¥552,796,800 is stated.
- Stated per-share price: Disposal price specified at ¥3,882 per share.
- Paid-in amount not incorporated into capital: The filing explicitly states contributions will not be added to capital, which affects equity accounting.
- Insufficient participant detail: The roles of the listed "234 Persons" and "84 Persons" are not explained, and vesting/allocation details are missing.
Insights
TL;DR: ORIX documents a ¥552.8M restricted-share consideration at ¥3,882 per share; this appears to be an employee compensation issuance with limited disclosure.
The filing supplies clear dollar amounts and per-share price, enabling straightforward calculation of shares involved (total contribution divided by disposal price). However, key investor metrics are missing: the exact number of shares issued, vesting terms, dilution impact, and whether these shares are newly issued or reallocated from treasury. Without those details, assessing EPS or ownership dilution impact is not possible from this filing alone.
TL;DR: Disclosure indicates an employee equity award mechanism but omits governance and plan specifics that investors typically expect.
The document confirms the mechanism (monetary grants converted to restricted shares) and the aggregate monetary amount, which is useful for governance review. It also specifically states paid-in amounts will not increase stated capital, a technical detail relevant to equity accounting. The filing does not include participant eligibility criteria, vesting schedules, or board approvals referenced, limiting assessment of alignment with shareholder interests.